Wintrust Investments LLC Sells 970 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wintrust Investments LLC trimmed its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.1% in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 44,748 shares of the pharmacy operator’s stock after selling 970 shares during the quarter. Wintrust Investments LLC’s holdings in Walgreens Boots Alliance were worth $2,354,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Harrington Investments INC increased its holdings in Walgreens Boots Alliance by 1.6% in the 2nd quarter. Harrington Investments INC now owns 14,739 shares of the pharmacy operator’s stock worth $775,000 after buying an additional 229 shares in the last quarter. Greylin Investment Mangement Inc. increased its holdings in Walgreens Boots Alliance by 0.8% in the 1st quarter. Greylin Investment Mangement Inc. now owns 29,298 shares of the pharmacy operator’s stock worth $1,608,000 after buying an additional 233 shares in the last quarter. Hudock Inc. increased its holdings in Walgreens Boots Alliance by 0.8% in the 2nd quarter. Hudock Inc. now owns 28,365 shares of the pharmacy operator’s stock worth $1,492,000 after buying an additional 239 shares in the last quarter. Cornerstone Wealth Management LLC increased its holdings in Walgreens Boots Alliance by 3.7% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 6,743 shares of the pharmacy operator’s stock worth $355,000 after buying an additional 242 shares in the last quarter. Finally, Balentine LLC increased its holdings in Walgreens Boots Alliance by 4.7% in the 1st quarter. Balentine LLC now owns 5,492 shares of the pharmacy operator’s stock worth $302,000 after buying an additional 249 shares in the last quarter. Institutional investors own 55.65% of the company’s stock.

NASDAQ WBA traded up $1.04 during trading hours on Wednesday, reaching $49.26. The company’s stock had a trading volume of 66,079 shares, compared to its average volume of 5,797,803. The firm’s 50-day moving average price is $48.20 and its 200-day moving average price is $51.26. The company has a quick ratio of 0.53, a current ratio of 0.77 and a debt-to-equity ratio of 0.34. Walgreens Boots Alliance, Inc. has a 1 year low of $33.36 and a 1 year high of $57.05. The company has a market capitalization of $42.61 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.41 and a beta of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, June 30th. The pharmacy operator reported $1.38 EPS for the quarter, topping the Zacks’ consensus estimate of $1.17 by $0.21. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The company had revenue of $34.03 billion for the quarter, compared to analysts’ expectations of $33.47 billion. During the same period in the previous year, the firm earned $0.71 EPS. The firm’s revenue was up 12.1% compared to the same quarter last year. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.75 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 10th. Investors of record on Friday, August 20th were issued a $0.477 dividend. The ex-dividend date of this dividend was Thursday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. This represents a $1.91 dividend on an annualized basis and a yield of 3.87%. Walgreens Boots Alliance’s payout ratio is currently 40.30%.

Several equities research analysts recently commented on WBA shares. Evercore ISI reiterated a “hold” rating and issued a $52.00 price objective on shares of Walgreens Boots Alliance in a report on Friday, July 2nd. Credit Suisse Group dropped their target price on Walgreens Boots Alliance from $50.00 to $48.00 and set a “neutral” rating on the stock in a research report on Friday, July 2nd. Wolfe Research reissued a “hold” rating and issued a $57.00 target price on shares of Walgreens Boots Alliance in a research report on Friday, July 2nd. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research report on Friday, June 18th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Walgreens Boots Alliance from $55.00 to $52.00 and set a “hold” rating on the stock in a research report on Friday, July 2nd. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $50.83.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

See Also: What is a growth and income fund?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.